Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations

Medicine, Oncology, Pharmacology +10

Cancer: Principles and Practice of Oncology.

Annals of Internal Medicine · 1988 · 1.9K citations

Medicine, Oncology, Oncology Nursing +10

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

Thomas C. Hamilton, Margaret A. Winker, Karen G. Louie et al. · Biochemical Pharmacology · 1985 · 540 citations

Medicine, Oncology, Pharmacology +14

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

Alfred M. Rogan, Thomas C. Hamilton, Robert C. Young et al. · Science · 1984 · 399 citations

Medicine, Oncology, Pharmacology +17

Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.

Hidetaka Masuda, R F Ozols, Gi‐Ming Lai et al. · PubMed · 1988 · 284 citations

Medicine, Molecular Biology, Oncology +17